TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34226462

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (20mg/kg/day for 14 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cefixime (16mg/kg/day for 14 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Azithromycin (20mg/kg/day for 14 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 62
Study: 34267133

Group type: EXPERIMENTAL
Intervention: Information given 14 days before surgery (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Information given 3 days before surgery (Group 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (Group 2)
Number of subjects: 50
Study: 34653002

Group type: EXPERIMENTAL
Intervention: Vojta therapy (specific tactile input)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study: 32020400

Group type: EXPERIMENTAL
Intervention: Microwave ablation plus chemotherapy
Number of subjects: 293

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 293
Study: 34170716

Group type: EXPERIMENTAL
Intervention: Angiography plus intravascular ultrasound (DSA + IVUS)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Angiography alone (DSA)
Number of subjects: 55
Study: 33161773

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 1986

Group type: COMPARATOR
Intervention: Standard blood pressure control
Number of subjects: 1986
Study: 34602467

Group type: EXPERIMENTAL
Intervention: Virtual Reality experience (30-min long, facilitated by research coordinator, for two weeks, 10 sessions)
Number of subjects: 24
Study: 32252716

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 2194

Group type: EXPERIMENTAL
Intervention: Red Warning Labels (WL)
Number of subjects: 2194

Group type: COMPARATOR
Intervention: Guideline Daily Amounts (GDA)
Number of subjects: 2194
Study: 36991381

Group type: EXPERIMENTAL
Intervention: Intermittent esketamine infusion (6-hour intravenous infusion every 2 weeks for 3 months, starting at 0.05 mg/kg/h, max 0.2 mg/kg/h)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous esketamine infusion (6 consecutive days of intravenous infusion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intermittent esketamine infusion
Number of subjects: 60
Study: 33586254

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Resistance Training with Blood Flow Restriction (RT+BFR)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 105
Study: 32583959

Group type: EXPERIMENTAL
Intervention: US-guided closed reduction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard landmark guided closed reduction
Number of subjects: 100
Study: 34453669

Group type: EXPERIMENTAL
Intervention: Advocacy program
Number of subjects: 37

Group type: COMPARATOR
Intervention: Waitlist-control
Number of subjects: 37
Study: 33456366

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate (CPM) 8 mg intravenous before induction of anesthesia
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (Control Group)
Number of subjects: 76
Study: 36102596

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32144735

Group type: EXPERIMENTAL
Intervention: Preoperative endocrine therapy concurrent with chemotherapy for 24 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 70
Study: 33886921

Group type: EXPERIMENTAL
Intervention: Mechanical restraint (bandage, tissues, sheets)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Control of aggressive behavior
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Prevention of falls
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Protection
Number of subjects: 162
Study: 32560632

Group type: EXPERIMENTAL
Intervention: Liver venous deprivation (LVD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Portal vein embolization (PVE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: LVD
Number of subjects: 64

Group type: COMPARATOR
Intervention: PVE
Number of subjects: 64
Study: 35651610

Group type: EXPERIMENTAL
Intervention: G-CSF (5 μg/kg every day for 6 days, then every other day until day 18)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (standard therapy)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 111
Study: 34117198

Group type: EXPERIMENTAL
Intervention: Concomitant administration of CYD‐TDV and Tdap vaccine
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Sequential administration of CYD‐TDV and Tdap vaccine
Number of subjects: 688

Group type: COMPARATOR
Intervention: Both groups (concomitant and sequential)
Number of subjects: 688
Study: 32654663

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ferric derisomaltose (FDI)
Number of subjects: 26
Study: 36775528

Group type: EXPERIMENTAL
Intervention: Pilates training 3 times a week for 8 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Home exercise program for 8 weeks (Control Group)
Number of subjects: 42
Study: 34477139

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection and splint treatment
Number of subjects: 168
Study: 34750225

Group type: EXPERIMENTAL
Intervention: d-amphetamine (dAMPH)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 33885235

Group type: EXPERIMENTAL
Intervention: 16 mg astaxanthin orally daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35434911

Group type: EXPERIMENTAL
Intervention: Nurse-led lifestyle-related risk factor modification intervention
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 224
Study: 33758940

Group type: EXPERIMENTAL
Intervention: Vegetable Intervention (VI) - daily provision of vegetables in amounts and types recommended by the DGA (∼270 g/day) for 8 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 110
Study: 32854965

Group type: EXPERIMENTAL
Intervention: Geriatric Acute and Post‐acute Fall Prevention intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study: 36463266

Group type: EXPERIMENTAL
Intervention: Positive memory training
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Sham intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: No training
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Positive memory training and Sham intervention
Number of subjects: 96
Study: 33840085

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Terazosin plus Enalapril
Number of subjects: 40
Study: 35241176

Group type: EXPERIMENTAL
Intervention: Functional standing frame programme (30 min. standing plus sit‐to‐stand repetitions) plus 15 min of usual physiotherapy daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual physiotherapy (45 min) daily
Number of subjects: 45
Study: 35768113

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 8 weeks preoperatively
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo capsules daily for 8 weeks preoperatively
Number of subjects: 500
Study: 34418380

Group type: EXPERIMENTAL
Intervention: Enhanced postoperative surveillance interventions (admitting to higher care ward, increasing nursing observations, assigning bed in view of nursing station, allowing family members to stay, placing surveillance guide at bedside)
Number of subjects: 28892

Group type: COMPARATOR
Intervention: Standard postoperative care (control group)
Number of subjects: 28892

Group type: EXPERIMENTAL
Intervention: High-risk patients (intervention group)
Number of subjects: 28892

Group type: COMPARATOR
Intervention: Low-risk patients (control group)
Number of subjects: 28892
Study: 32623402

Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium breve A1 (2×10^10 CFU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34282985

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase (baseline ≥5 cerebral microbleeds)
Number of subjects: 113
Study: 34142636

Group type: EXPERIMENTAL
Intervention: Avoidance Behavior (AB)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Cognitions (COG)
Number of subjects: 428
Study: 34343140

Group type: EXPERIMENTAL
Intervention: Rehabilitative therapies such as exercise, respiratory muscle training, assistive devices, and manual therapy and stretching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rehabilitative exercise programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tele-rehab
Number of subjects: 0
Study: 32599148

Group type: EXPERIMENTAL
Intervention: System-level intervention to improve serious illness communication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Life Priorities Scale (nonvalidated survey)
Number of subjects: 0
Study: 36070584

Group type: EXPERIMENTAL
Intervention: MWF + activeDL
Number of subjects: 18

Group type: COMPARATOR
Intervention: MWF alone
Number of subjects: 18
Study: 35665947

Group type: EXPERIMENTAL
Intervention: 7 days amoxicillin 1 g + clarithromycin 500 mg + vonoprazan 20 mg twice per day
Number of subjects: 244

Group type: COMPARATOR
Intervention: 14 days amoxicillin 1 g + clarithromycin 500 mg + PPI (omeprazole or esomeprazole or rabeprazole) 20 mg twice/day
Number of subjects: 244
Study: 33676366

Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverage (SSB) intake
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Meat intake
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no SSB or meat intake)
Number of subjects: 32
Study: 32871029

Group type: EXPERIMENTAL
Intervention: HD-DXM plus rhTPO
Number of subjects: 196

Group type: COMPARATOR
Intervention: HD-DXM monotherapy
Number of subjects: 196
Study: 35222267

Group type: EXPERIMENTAL
Intervention: Hysteroscopy with saline irrigation during the early mid‐follicular phase (day 5‐7) of a stimulation cycle.
Number of subjects: 228

Group type: COMPARATOR
Intervention: No irrigation (control group).
Number of subjects: 228
Study: 33207997

Group type: EXPERIMENTAL
Intervention: Toxoplasma-seropositive mothers (case group)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Toxoplasma-seronegative mothers (control group)
Number of subjects: 137
Study: 32233570

Group type: EXPERIMENTAL
Intervention: Invariant probability measure $
u_{	ext{λ}}^*$
Number of subjects: 0
Study: 35322134

Group type: EXPERIMENTAL
Intervention: Smoke evacuation system (SES)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No smoke evacuation system (no SES)
Number of subjects: 122
Study: 32008730

Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone 400 mg twice daily
Number of subjects: 4153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4153
Study: 36348211

Group type: EXPERIMENTAL
Intervention: Web-app intervention for 6 months based on the Behaviour Change Wheel Model
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group (no web-app intervention)
Number of subjects: 224
Study: 34391272

Group type: EXPERIMENTAL
Intervention: Rotational movement exercises (16 training sessions over 4 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (CG) with no training applied
Number of subjects: 73
Study: 32471476

Group type: EXPERIMENTAL
Intervention: NUCOD program delivered through trained diabetes nurses
Number of subjects: 1236

Group type: COMPARATOR
Intervention: Usual treatment group
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: NUCOD program
Number of subjects: 1236
Study: 36397237

Group type: EXPERIMENTAL
Intervention: Comprehensive return to work intervention including educational material, face-to-face educational session, and individualized telephone counseling sessions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comprehensive return to work intervention
Number of subjects: 0
Study: 34235780

Group type: EXPERIMENTAL
Intervention: Air mixed with emissions from cooking (PM2.5: 96.1 μg/m3)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Air mixed with emissions from candles (PM2.5: 89.8 μg/m3)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Clean filtered air (PM2.5: 5.8 μg/m3)
Number of subjects: 36
Study: 32521904

Group type: EXPERIMENTAL
Intervention: GEMOX (Gemcitabine and Oxaliplatin)
Number of subjects: 68

Group type: COMPARATOR
Intervention: GDP (Gemcitabine, Cisplatin, and Dexamethasone)
Number of subjects: 68
Study: 34001152

Group type: EXPERIMENTAL
Intervention: WHOQOL‐BREF(PT) instrument
Number of subjects: 351
Study: 32007179

Group type: EXPERIMENTAL
Intervention: Oswestry Disability Scale for Low Back Pain
Number of subjects: 162
Study: 36311243

Group type: EXPERIMENTAL
Intervention: Routine rehabilitation + blood flow restriction training (RR + BFRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine rehabilitation (RR)
Number of subjects: 40
Study: 32965030

Group type: EXPERIMENTAL
Intervention: Topical Calendula officinalis
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard of care (Sorbolene: 10% glycerine in cetomacragol cream)
Number of subjects: 82
Study: 35870478

Group type: EXPERIMENTAL
Intervention: Computerised decision support system (CDSS) for antimicrobial stewardship
Number of subjects: 11384

Group type: COMPARATOR
Intervention: Standard antibiotic stewardship measures (Control)
Number of subjects: 11384
Study: 32864723

Group type: EXPERIMENTAL
Intervention: Care as usual plus consultations with a patient navigator (oncology nurse)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 89
Study: 35511938

Group type: EXPERIMENTAL
Intervention: Vopratelimab with Nivolumab
Number of subjects: 201
Study: 33994311

Group type: EXPERIMENTAL
Intervention: IN·clued program
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1401
Study: 36097326

Group type: EXPERIMENTAL
Intervention: Telephone-based, peer-led diabetes self-management intervention
Number of subjects: 25
Study: 33249467

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg (or dose-reduced 30 mg)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 614

Group type: COMPARATOR
Intervention: VKA
Number of subjects: 614
Study: 36193812

Group type: EXPERIMENTAL
Intervention: 250 or 600 mL m‐2 of cow's milk
Number of subjects: 51

Group type: COMPARATOR
Intervention: Matching equienergetic sugar water (control)
Number of subjects: 51
Study: 34371381

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 495

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 495
Study: 32878764

Group type: EXPERIMENTAL
Intervention: BEACON Caresystem (model-based decision support system)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Routine care (current care)
Number of subjects: 274
Study: 34798726

Group type: EXPERIMENTAL
Intervention: continuous exhaust‐only ventilation system
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: intermittent powered central‐fan‐integrated‐supply (CFIS) system
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: continuous balanced system with an energy recovery ventilator (ERV)
Number of subjects: 40
Study: 33398627

Group type: EXPERIMENTAL
Intervention: mRYGB
Number of subjects: 45

Group type: COMPARATOR
Intervention: SG
Number of subjects: 45

Group type: COMPARATOR
Intervention: GCP
Number of subjects: 45
Study: 35147719

Group type: EXPERIMENTAL
Intervention: Coated TKA
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard TKA
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Elevated IL-8 values
Number of subjects: 120
Study: 32970234

Group type: EXPERIMENTAL
Intervention: Hayward green kiwifruit with beef meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hort 16A gold kiwifruit with beef meal
Number of subjects: 12
Study: 32673233

Group type: EXPERIMENTAL
Intervention: Guided web-based self-management intervention (iFightDepression tool)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Web-based progressive muscle relaxation (active control)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Guided web-based self-management intervention
Number of subjects: 348
Study: 33689454

Group type: EXPERIMENTAL
Intervention: Closed-Loop Control (CLC) system
Number of subjects: 100
Study: 36172955

Group type: EXPERIMENTAL
Intervention: Dietitian-led intervention with motivational interviewing during weekly calls
Number of subjects: 187

Group type: COMPARATOR
Intervention: Minimal nonclinical staff support
Number of subjects: 187
Study: 33465772

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab injections every 4, 6, or 8 weeks for 1 year
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Discontinuation of anti-VEGF therapy after 1 year of treatment
Number of subjects: 191
Study: 34214881

Group type: EXPERIMENTAL
Intervention: Alcohol drinkers (>0 g/day of alcohol intake)
Number of subjects: 1783

Group type: COMPARATOR
Intervention: Non-drinkers (0 g/day of alcohol intake)
Number of subjects: 1783
Study: 34608857

Group type: EXPERIMENTAL
Intervention: Bilevel PAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 0
Study: 34252635

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) administration
Number of subjects: 50
Study: 36243123

Group type: EXPERIMENTAL
Intervention: 15% dextrose PrT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% dextrose PrT
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 60
Study: 33104258

Group type: EXPERIMENTAL
Intervention: Sulfotanshinone sodium injection combined with tirofiban (n = 99)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Tirofiban alone (n = 70)
Number of subjects: 169
Study: 34519099

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) with continued behavioural support
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Behavioural support
Number of subjects: 34
Study: 32209067

Group type: EXPERIMENTAL
Intervention: Food and beverage advertisements
Number of subjects: 1610

Group type: EXPERIMENTAL
Intervention: Food advertisements on weekends, afternoons, and during soap operas
Number of subjects: 1610

Group type: EXPERIMENTAL
Intervention: Transnational and local food and beverage companies
Number of subjects: 1610
Study: 32828785

Group type: EXPERIMENTAL
Intervention: Oral calcium supplements
Number of subjects: 5147

Group type: COMPARATOR
Intervention: No calcium supplements
Number of subjects: 5147
Study: 32196110

Group type: EXPERIMENTAL
Intervention: Intradiscal gelified ethanol injection (Discogel)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intradiscal combination of pulsed radiofrequency and gelified ethanol injection (PRF+Discogel)
Number of subjects: 36
Study: 32146259

Group type: EXPERIMENTAL
Intervention: Two fractions of 13.5 Gy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Single fraction of 19 Gy
Number of subjects: 170
Study: 36279690

Group type: EXPERIMENTAL
Intervention: Intravaginal laser therapy (2 courses within 1 month)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Hyaluronic acid suppositories (3 times/week for 3 months)
Number of subjects: 43
Study: 33561528

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 32723843

Group type: EXPERIMENTAL
Intervention: Dexcom G6 CGM system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 0
Study: 35871944

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee
Number of subjects: 18

Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 18
Study: 32584072

Group type: EXPERIMENTAL
Intervention: Self-reported social support
Number of subjects: 0
Study: 32107188

Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Ranibizumab (0.5 mg)
Number of subjects: 277
Study: 37354171

Group type: EXPERIMENTAL
Intervention: AI algorithm for detecting paroxysmal AF from ECGs in SR
Number of subjects: 142310
Study: 35379314

Group type: EXPERIMENTAL
Intervention: Active daily use of Alpha-Stim AID for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham Alpha-Stim AID
Number of subjects: 0
Study: 32427325

Group type: EXPERIMENTAL
Intervention: Family Centered Pediatric Advance Care Planning for Teens With Cancer intervention (Session 1 of 3 sessions)
Number of subjects: 80
Study: 35922234

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 4280

Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test (FIT)
Number of subjects: 4280

Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach
Number of subjects: 4280
Study: 33352495

Group type: EXPERIMENTAL
Intervention: Herbal drug of Coccinia grandis (500 mg once daily for three months)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo (once daily for three months)
Number of subjects: 158
Study: 32812025

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (400 mg), Daclatasvir (60 mg), Ribavirin (1200 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 48
Study: 33789151

Group type: EXPERIMENTAL
Intervention: Pragmatic trials
Number of subjects: 4337
Study: 33172290

Group type: EXPERIMENTAL
Intervention: Atole
Number of subjects: 800

Group type: COMPARATOR
Intervention: Fresco
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Maternal exposure to Atole
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Stunting during early childhood among girls
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Younger age at first pregnancy (<20 years)
Number of subjects: 800
Study: 36169938

Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitor monotherapy after 3 months of DAPT
Number of subjects: 2993

Group type: COMPARATOR
Intervention: Prolonged DAPT
Number of subjects: 2993
Study: 33451691

Group type: EXPERIMENTAL
Intervention: Short Musculoskeletal Function Assessment (SMFA)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Lower Extremity Functional Scale (LEFS)
Number of subjects: 136

Group type: COMPARATOR
Intervention: EuroQoL-5D (EQ-5D)
Number of subjects: 136